Expression of CD52 in peripheral T-cell lymphoma

被引：48

作者：

Piccaluga, Pier Paolo ^{[1
]}

Agostinelli, Claudio ^{[1
]}

Righi, Simona ^{[1
]}

Zinzani, Pier Luigi ^{[1
]}

Pileri, Stefano A. ^{[1
]}

机构：

[1] Univ Bologna, Inst Hematol & Med Oncol L&A Seragnoli, S Orsola Malpighi Hosp, I-40138 Bologna, Italy

来源：

HAEMATOLOGICA | 2007年 / 92卷 / 04期

关键词：

T-cell lymphoma; CD52; expression;

D O I：

10.3324/haematol.10767

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Peripheral T-cell lymphoma unspecified (PTCL/U) is a rare tumor characterized by poor treatment response and a dismal prognosis. We studied CD52 expression in 97 PTCL/U cases by immunohistochemistry on tissue-microarrays. Furthermore, CD52 gene expression was studied in 28 cases for which RNA was available. We found that CD52 is expressed in approximately 40% of PTCLs/U at the same level as in normal T-lymphocytes. Although other factors may play a role in the in vivo response to alemtuzumab, an anti-CD52 monoclonal antibody, the estimation of CD52 expression may provide a rationale for the selection of patients with a higher probability of treatment response.

引用

页码：566 / 567

页数：2

共 50 条

[21] T-cell dysfunction in CLL is mediated through expression of Siglec-10 ligands CD24 and CD52 on CLL cells
van Bruggen, Jaco A. C.
Peters, Fleur S.
Mes, Morris
Rietveld, Joanne M.
Cerretani, Elisa
Cretenet, Gaspard
van Kampen, Roel
Jongejan, Aldo
Moerland, Perry D.
Melenhorst, J. Joseph
van der Windt, Gerritje J. W.
Eldering, Eric
Kater, Arnon P.
BLOOD ADVANCES, 2024, 8 (17) : 4633 - 4646
[22] Peripheral T-cell lymphoma
Cookson, Emma
LANCET HAEMATOLOGY, 2021, 8 (01): : E17 - E17
[23] PERIPHERAL T-CELL LYMPHOMA
BOEHRINGER, B
OSTRONOFF, M
MACEDO, MCA
CONCHON, M
MEDEIROS, RS
MASSUMOTO, CM
DULLEY, F
MENEZES, Y
VASALO, J
LLACCER, PD
POZZI, D
CHAMONE, DF
BLOOD, 1994, 84 (10) : A639 - A639
[24] PERIPHERAL T-CELL LYMPHOMA
LIANG, R
TODD, D
CHAN, TK
WONG, KL
HO, F
LOKE, SL
JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (05) : 750 - 755
[25] Peripheral T-cell lymphoma
Canellos, GP
ANNALS OF ONCOLOGY, 1998, 9 : 2 - 2
[26] Peripheral T-cell lymphoma
Foss, Francine M.
Zinzani, Pier Luigi
Vose, Julie M.
Gascoyne, Randy D.
Rosen, Steven T.
Tobinai, Kensei
BLOOD, 2011, 117 (25) : 6756 - 6767
[27] PERIPHERAL T-CELL LYMPHOMA
ARMITAGE, JO
GREER, JP
LEVINE, AM
WEISENBURGER, DD
FORMENTI, SC
BAST, M
CONLEY, S
PIERSON, J
LINDER, J
COUSAR, JB
NATHWANI, BN
CANCER, 1989, 63 (01) : 158 - 163
[28] PERIPHERAL T-CELL LYMPHOMA
CLERICI, T
BACHELEZ, H
BAGOT, M
WECHSLER, J
ZELLER, J
HAIOUN, C
KUENTZ, M
ENNI, T
TOURAINE, R
ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 1987, 114 (11): : 1364 - 1366
[29] PERIPHERAL T-CELL LYMPHOMA
WATANABE, S
MUKAI, K
SHIMOYAMA, M
CANCER AND METASTASIS REVIEWS, 1988, 7 (03) : 243 - 261
[30] Peripheral T-Cell Lymphoma With Aberrant Expression of CD30, CD15, and CD20
Song, Joo Y.
Strom, Ted
Raffeld, Mark
Pittaluga, Stefania
Jaffe, Elaine S.
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (32) : E789 - E791

← 1 2 3 4 5 →